🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid British shipping. Vendors market the drug there before directing buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals administering substances of uncertain source.

Some experts stated the popularity for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, risking fines, prosecution or imprisonment.

Service Reaction and Content Removal

According to the social media company, the platform has taken down violative content and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the platform safe and investing in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also discovered communities with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.

After minutes of entering one group, a seller posted contact information, where most transactions occur. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, medical conditions or past usage.

Item Details and Pricing

Inside these communities, posts show dark colored packages with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram stated it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her team has previously encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to possibly significant health risks”.